A recent study reveals that individuals who come off blockbuster slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who end conventional diet and exercise plans.
Findings released in a prominent health publication points out that while overweight individuals can lose substantial amounts of their body weight while on the medication, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals buying such medications need to be informed of the danger of rapid rebound weight gain when the therapy is stopped," warns expert Dr. Susan Jebb.
That rate of recovery means a reversion to original weight in about a year and a half.
Analyzing Therapies
The analysis, which reviewed dozens of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with conventional dieting.
The team point out that people who shed pounds through diet and exercise usually see a slower weight regain—perhaps 0.1 kg a month—after stopping.
Understanding the Quick Regain
Nutrition scientists suggest the way of the jabs explains the heightened weight return.
These medications mimic a body's own chemical called GLP-1, which moderates appetite.
"Artificially providing the hormone concentrations far above than normal may cause the body to generate a reduced amount of its own natural GLP-1, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this GLP-1 'fix' leads to hunger is no longer kept in check, making overeating far more likely."
A Lifelong Disease?
Medical guidelines recommend the jabs for people with weight-linked health risks, accompanied by recommended lifestyle changes.
A number of clinicians say that, considering the high risk of weight regain, the therapy might need to be life-long.
This view is echoed by drug manufacturers, who note that the findings "underscore the persistent nature of obesity," comparing it to managing diseases like hypertension.
Patient Accounts
Individuals who have discontinued the medication describe a intense resurgence of appetite.
"It felt as if something that goes on and I was suddenly ravenous," said a patient.
This difficulty is exacerbated if patients have not adopted lasting dietary or behavioural changes during therapy.
Widespread Adoption
Recent estimates indicate that millions of people in the UK have used these injections in the last 12 months, with desire being substantial.
- Adoption is more common among females compared to males.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
Finally, experts stress that while the jabs are effective agents for weight loss, they are not a permanent solution and lasting health benefits hinges on combined lifestyle changes.
